
Glycotest
Glycotest Inc.: Global provider of non-invasive blood tests for early detection and treatment of liver diseases.
- 30
- Private company
- Merion Station, PA, USUnited States
Glycotest is a liver disease diagnostics company commercializing glycoprotein biomarker science through blood tests for early detection and surveillance of liver cancer; it was established to commercialize discoveries made at Drexel University College of Medicine and the Baruch S. Blumberg Institute. Its HCC Panel blood test is developed for surveillance of hepatocellular carcinoma in patients at increased risk of liver cancer.
Glycotest is also developing its platform for diagnostic programs targeting cholangiocarcinoma and liver fibrosis. Glycotest holds exclusive worldwide rights to proprietary glycoprotein biomarkers, biomarker panels, algorithms, and assay technologies. Current surveillance methods can miss early-stage liver cancers.
Similar Companies

Mellitus
mellitusllc.com
CanDiag

Harbinger Health
BioDetego

Eventus Diagnostics
OncoHealth
oncohealthcorp.com

Gryphon Bio
gryphonbio.com

Chosen Diagnostics

Diabetomics
diabetomics.com

SynapDx

Avant Diagnostics
Group K Diagnostics

Gregor Diagnostics

Molecular Stethoscope
superfluiddx.com

Hawkeye Bio
hawkeyebio.com

Ridge Diagnostics
ridgedx.com

Acuamark Diagnostics
acuamarkdx.com

Babson Diagnostics
babsondx.com

GlycoMimetics
glycomimetics.com

BioChip Labs
biochiplabs.com
Quick Facts
Who are Glycotest's competitors?
Companies similar to Glycotest include Mellitus, CanDiag, Harbinger Health and BioDetego.
When was Glycotest founded?
Glycotest was founded in 2011.
Where is Glycotest's headquarters located?
Glycotest's headquarters is located in Merion Station, PA, US.
When was Glycotest's last funding round?
Glycotest's most recent funding round was for $3.2M (USD) in June 2026.
How much disclosed funding has Glycotest raised?
As of Jun 30, 2026, Glycotest has disclosed funding of $13.2M (USD). Undisclosed round amounts are excluded.
How many employees does Glycotest have?
Glycotest has 30 employees as of Feb 4, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- Tags
- Also Known As
- Glycotest Inc.
- Headquarters
- 613 Schiller Ave.
- Merion Station, PA, 19066
- US
- SEC CIK
- 0002144866
- EIN
- 46-1382912
- NAICS
- 620000Health Care and Social Assistance
- 623000Nursing and Residential Care Facilities
- SIC
- 8000Health Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 325000Chemical Manufacturing
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 325410Pharmaceutical and Medicine Manufacturing
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8700Engineering, Accounting, Research, Management, And Related Services
- 2830Drugs
- 8730Research, Development, And Testing Services
- 2834Pharmaceutical Preparations
- 8731Commercial Physical and Biological Research